Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Current Opinion in Hematology|January 7, 2020
Relapsed or primary refractory AML: moving past MEC and FLAG-idaKristin Koenig, Alice MimsAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 3, 2020
The Changing Landscape of Treatment in Acute Myeloid LeukemiaKristin Koenig, Alice Mims, Mark J Levis, et al.Cancers|January 10, 2026
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation TrialShivani Handa, Kristin Koenig, Qiuhong Zhao, et al.Cancer Discovery|December 17, 2016
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer RelapseMarco Demaria, Monique N O'Leary, Jianhui Chang, et al.JBMR Plus|March 29, 2021
Longitudinal Functional Study of Murine Aging: A Resource for Future Study DesignsDaniel S Evans, Monique N O'Leary, Ryan Murphy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AMLJoshua F Zeidner, Tara L Lin, Rina Li Welkie, et al.Pageof 1